MAPT and Alzheimer disease: Clinical case series documenting patients with CTE have demonstrated the deposition of NFTs, an end product of tau hyperphosphorylation, in perivascular regions, which is a distinct difference from other tauopathies such as Alzheimer’s disease (AD).